Show
Sort by
-
- Journal Article
- A1
- open access
Equine metabolism of the growth hormone secretagogue MK-0677 in vitro and in urine and plasma following oral administration
-
Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)
-
- Journal Article
- A1
- open access
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists
-
- Journal Article
- A1
- open access
A new cannabinoid receptor 1 selective agonist evading the 2021 'China ban': ADB‐FUBIATA
-
- Journal Article
- A1
- open access
Are the N-demethylated metabolites of U-47700 more active than their parent compound? In vitro mu-opioid receptor activation of N-desmethyl-U-47700 and N,N-bisdesmethyl-U-47700
-
- Journal Article
- A1
- open access
Identification of equine in vitro metabolites of seven non-steroidal selective androgen receptor modulators for doping control purposes
-
Long-term stability study and evaluation of intact steroid conjugate ratios after the administration of endogenous steroids
-
- Journal Article
- A1
- open access
Equine metabolism of the selective androgen receptor modulator AC-262536 in vitro and in urine, plasma and hair following oral administration
-
Investigation of the urinary excretion of prednisolone and metabolites after nasal administration : relevance to doping control
-
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB1 receptor activation assays: Part I-Synthesis, analytical characterization, and binding affinity for human CB1 receptors